Deciphering the therapeutic potential of trimetazidine in rheumatoid arthritis via targeting mi-RNA128a, TLR4 signaling pathway, and adenosine-induced FADD-microvesicular shedding: In vivo and in silico study
2024Frontiers in PharmacologyJournalOpen access
10.3389/fphar.2024.1406939Full text8 citations